179 related articles for article (PubMed ID: 2940122)
1. The use of pure follicle-stimulating hormone for ovulation induction in normal ovulatory women in an in vitro fertilization program.
Russell JB; Polan ML; DeCherney AH
Fertil Steril; 1986 Jun; 45(6):829-33. PubMed ID: 2940122
[TBL] [Abstract][Full Text] [Related]
2. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.
Turhan NO; Artini PG; D'Ambrogio G; Droghini F; Battaglia C; Genazzani AD; Volpe A; Genazzani AR
J Assist Reprod Genet; 1993 Jan; 10(1):15-20. PubMed ID: 8499674
[TBL] [Abstract][Full Text] [Related]
4. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
[TBL] [Abstract][Full Text] [Related]
5. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.
Bernardus RE; Jones GS; Acosta AA; Garcia JE; Liu HC; Jones DL; Rosenwaks Z
Fertil Steril; 1985 Mar; 43(3):373-8. PubMed ID: 3920087
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy of high-dose pure follicle-stimulating hormone versus human menopausal gonadotropins for in vitro fertilization.
Check JH; O'Shaughnessy A; Nazari A; Hoover L
Gynecol Obstet Invest; 1995; 40(2):117-9. PubMed ID: 8575688
[TBL] [Abstract][Full Text] [Related]
7. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function.
Polan ML; Daniele A; Russell JB; DeCherney AH
J Clin Endocrinol Metab; 1986 Dec; 63(6):1284-91. PubMed ID: 3097055
[TBL] [Abstract][Full Text] [Related]
8. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
9. The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.
Muasher SJ; Garcia JE; Rosenwaks Z
Fertil Steril; 1985 Jul; 44(1):62-9. PubMed ID: 3924669
[TBL] [Abstract][Full Text] [Related]
10. Ovulation induction for assisted reproduction.
Scott RT; Rosenwaks Z
J Reprod Med; 1989 Jan; 34(1 Suppl):108-14. PubMed ID: 2497245
[TBL] [Abstract][Full Text] [Related]
11. In vitro fertilization and embryo transfer: an individualized approach to ovulation induction.
Taymor ML; Seibel MM; Oskowitz SP; Smith DM; Lee G
J In Vitro Fert Embryo Transf; 1985 Sep; 2(3):162-5. PubMed ID: 3932569
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
13. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program.
Scoccia B; Blumenthal P; Wagner C; Prins G; Scommegna A; Marut EL
Fertil Steril; 1987 Sep; 48(3):446-9. PubMed ID: 3114011
[TBL] [Abstract][Full Text] [Related]
14. Ovarian stimulation with pure follicle-stimulating hormone/human menopausal gonadotropin and improved laparoscopic aspiration needles influence the success of an in vitro fertilization program.
Eisermann J; Yang V; Register K; Swank N; Strickler RC
Fertil Steril; 1989 Jan; 51(1):112-6. PubMed ID: 2521323
[TBL] [Abstract][Full Text] [Related]
15. Superovulation of mice with human menopausal gonadotropin or pure follicle-stimulating hormone in combination with human chorionic gonadotropin and the effects of oocyte aging on in vitro fertilization.
Edirisinghe WR; Law HY; NG SC; Chia CM; Ratnam SS
J In Vitro Fert Embryo Transf; 1986 Oct; 3(5):314-8. PubMed ID: 3097220
[TBL] [Abstract][Full Text] [Related]
16. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
17. Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization.
Veeck LL; Wortham JW; Witmyer J; Sandow BA; Acosta AA; Garcia JE; Jones GS; Jones HW
Fertil Steril; 1983 May; 39(5):594-602. PubMed ID: 6404659
[TBL] [Abstract][Full Text] [Related]
18. The use of high-dose human menopausal gonadotropin in an in vitro fertilization program.
Laufer N; DeCherney AH; Haseltine FP; Polan ML; Mezer HC; Dlugi AM; Sweeney D; Nero F; Naftolin F
Fertil Steril; 1983 Dec; 40(6):734-41. PubMed ID: 6228444
[TBL] [Abstract][Full Text] [Related]
19. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
20. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
Garcia JE; Padilla SL; Bayati J; Baramki TA
Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
